Markets https://www.benzinga.com/views/taxonomy/term/2 en Aequus Announces Issuance of Stock Options https://www.benzinga.com/pressreleases/20/06/g16186356/aequus-announces-issuance-of-stock-options <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p align="justify">VANCOUVER, British Columbia, June 04, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSXV:<a class="ticker" href="https://www.benzinga.com/stock/AQS#TSXV" rel="nofollow">AQS</a>, OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/AQSZF#OTCQB" rel="nofollow">AQSZF</a>) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, announced today a grant of 1,124,337 stock options to the Chief Operating Officer to replace the same number of previously issued options that expired on May 31, 2020. These stock options are exercisable at a price of $0.09 per share, for a term of eight years. The terms of the stock options granted on June 4, 2020 are in accordance with the Company&#039;s Stock Option Plan.<br /></p> <p align="justify">ABOUT AEQUUS PHARMACEUTICALS INC.</p> <p align="justify">Aequus Pharmaceuticals Inc. (TSXV:<a class="ticker" href="https://www.benzinga.com/stock/AQS#TSXV" rel="nofollow">AQS</a>, OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/AQSZF#OTCQB" rel="nofollow">AQSZF</a>) is a growing specialty pharmaceutical company focused on developing and commercializing high quality, differentiated products. Aequus has grown its sales and marketing efforts to include several commercial products in ophthalmology and transplant. Aequus plans to build on its Canadian commercial platform through the launch of additional products that are either created internally or brought in through an acquisition or ...</p><p><a href=https://www.benzinga.com/pressreleases/20/06/g16186356/aequus-announces-issuance-of-stock-options alt=Aequus Announces Issuance of Stock Options>Full story available on Benzinga.com</a></p> AQSZF TSXV:AQS Markets Press Releases Fri, 05 Jun 2020 02:30:10 +0000 Globe Newswire 16186356 at https://www.benzinga.com History Suggests Record 50-Day Stock Market Rally May Be Just The Beginning https://www.benzinga.com/analyst-ratings/analyst-color/20/06/16182262/history-suggests-record-50-day-stock-market-rally-may-be-just-the-beginning <p>The S&amp;P 500 has gained a record 39.6% since it hit its 2020 low back on March 23. Not only has that rally erased much of the year&rsquo;s COVID-19-related losses, it&#39;s also the best 50-day stretch in the history of the market.</p> <p>After such a strong rally, traders are understandably getting uneasy&nbsp;the market is overbought and due for a pullback. However, from a purely historical perspective, the strongest 50-day periods have generally led to even more gains over the year that follows, according to LPL Financial Senior Market Strategist Ryan Detrick.</p> <h3><strong>A Closer Look</strong></h3> <p>On Thursday, <a href="https://lplresearch.com/2020/06/04/best-50-day-rally-ever/">Detrick looked</a> at the seven other times since the S&amp;P 500 ...</p><p><a href=https://www.benzinga.com/analyst-ratings/analyst-color/20/06/16182262/history-suggests-record-50-day-stock-market-rally-may-be-just-the-beginning alt=History Suggests Record 50-Day Stock Market Rally May Be Just The Beginning>Full story available on Benzinga.com</a></p> Analyst Color Long Ideas LPL Financial Ryan Detrick SPX SPY Futures Top Stories Markets Analyst Ratings Trading Ideas SPY US78462F1030 SPX Long Ideas Analyst Color Futures Top Stories Markets Analyst Ratings Trading Ideas Benzinga Thu, 04 Jun 2020 22:10:23 +0000 Wayne Duggan 16182262 at https://www.benzinga.com Michigan Dispensaries Offer Discounts To People With Cannabis-Related Convictions https://www.benzinga.com/markets/cannabis/20/06/16183343/michigan-dispensaries-offer-discounts-to-people-with-cannabis-related-convictions <p>Three Michigan provisioning centers have teamed up to offer a unique discount program geared specifically toward people caught up in the trap of marijuana prohibition.</p> <p>They are calling it the &ldquo;Redemption Discount.&rdquo;</p> <p>People convicted of marijuana-related felonies will get a 10% discount, while those convicted of&nbsp;marijuana-related misdemeanors will get a 5% discount at ...</p><p><a href=https://www.benzinga.com/markets/cannabis/20/06/16183343/michigan-dispensaries-offer-discounts-to-people-with-cannabis-related-convictions alt=Michigan Dispensaries Offer Discounts To People With Cannabis-Related Convictions>Full story available on Benzinga.com</a></p> Cannabis News Legal Markets News Cannabis Legal Markets Benzinga Thu, 04 Jun 2020 22:01:23 +0000 Javier Hasse 16183343 at https://www.benzinga.com Organic Flower Dives Into Psychedelics Investments, Hires New Talent https://www.benzinga.com/markets/cannabis/20/06/16183846/organic-flower-dives-into-psychedelics-investments-hires-new-talent <p>Pharmaceutical company&nbsp;<strong>Organic Flower Investments Group </strong>(CSE: SOW) (OTC: <a class="ticker" href="https://www.benzinga.com/stock/qilff#OTC">QILFF</a>)&nbsp;has formed a special committee&nbsp;to analyze profitable investments in the psychedelics space.</p> <p>This is part of an&nbsp;R&amp;D effort for&nbsp;medicine and biotech.</p> <p>The committee will focus on analyzing potential investments in these fields and initiating a series of ...</p><p><a href=https://www.benzinga.com/markets/cannabis/20/06/16183846/organic-flower-dives-into-psychedelics-investments-hires-new-talent alt=Organic Flower Dives Into Psychedelics Investments, Hires New Talent>Full story available on Benzinga.com</a></p> Cannabis organic flower Penny Stocks psychedelics QILFF Health Care Small Business Markets General QILFF Penny Stocks Cannabis Health Care Small Business Markets General Benzinga Thu, 04 Jun 2020 21:58:47 +0000 Jose Rodrigo Safdiye 16183846 at https://www.benzinga.com Cannabis Stock Gainers And Losers From June 4, 2020 https://www.benzinga.com/markets/cannabis/20/06/16184931/cannabis-stock-gainers-and-losers-from-june-4-2020 <p>&nbsp;</p> <h3>Gainers</h3> <p>&nbsp;</p> <p>&nbsp;</p> <ul> <li><strong>Greenlane Holdings&nbsp;</strong>(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gnln#NASDAQ">GNLN</a>) shares closed up 21.17% at $3.95</li> <p></p> <li><strong>Choom Holdings&nbsp;</strong>(OTC: <a class="ticker" href="https://www.benzinga.com/stock/choof#OTC">CHOOF</a>) shares closed up 20.29% at $0.13</li> <p></p> <li><strong>Cann Group&nbsp;</strong>(OTC: <a class="ticker" href="https://www.benzinga.com/stock/cnggf#OTC">CNGGF</a>) shares closed up 16.08% at $0.83</li> <p></p> <li><strong>Zelira Therapeutics&nbsp;</strong>(OTC: <a class="ticker" href="https://www.benzinga.com/stock/zldaf#OTC">ZLDAF</a>) shares closed up 13.42% at $0.04</li> <p></p> <li><strong>Nine Energy ...</strong></li></ul><p><a href=https://www.benzinga.com/markets/cannabis/20/06/16184931/cannabis-stock-gainers-and-losers-from-june-4-2020 alt=Cannabis Stock Gainers And Losers From June 4, 2020>Full story available on Benzinga.com</a></p> ARNA BMMJ Cannabis CBWTF CHOOF CNGGF CNPOF CWBHF FLOOF GNLN HLIX LQSIF NINE Penny Stocks stocks ZLDAF After-Hours Center Markets ARNA US0400471027 LQSIF HLIX CBWTF BMMJ CHOOF CNGGF ZLDAF NINE US65441V1017 CNPOF CWBHF FLOOF GNLN Penny Stocks Cannabis After-Hours Center Markets Benzinga Thu, 04 Jun 2020 21:55:46 +0000 Jose Rodrigo Safdiye 16184931 at https://www.benzinga.com Rubicon Organics Closes Final $2.0 Million Tranche of $13.5 Million Upsized Private Placement https://www.benzinga.com/pressreleases/20/06/g16185017/rubicon-organics-closes-final-2-0-million-tranche-of-13-5-million-upsized-private-placement <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p align="justify">VANCOUVER, British Columbia, June 04, 2020 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/ROMJ#CSE" rel="nofollow">ROMJ</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/ROMJF#OTCQX" rel="nofollow">ROMJF</a>) ("Rubicon Organics" or the "Company") is pleased to announce that it has closed the second and final tranche of its previously announced upsized non-brokered private placement of 851,064 units of the Company ("Units") at a price of $2.35 per Unit for aggregate gross proceeds of $2.0 million (together with the first tranche, the "Offering").  In aggregate, the Company has raised a total of $13.5 million under the first and second tranches of the Offering.<br /></p> <p align="justify">"Closing this $13.5 million private placement marks an important milestone on our journey to become Canada&#039;s leading organic cannabis company," stated Jesse McConnell, CEO.</p> <p align="justify">Each Unit is comprised of one common share of the Company (each, a "Common Share") and one Common Share purchase warrant of the Company (each, a "Warrant"). Each Warrant entitles the holder thereof to acquire one Common Share at a price of $3.25 per Common Share at any time during the 12-month period following the closing date.</p> <p align="justify">The securities issued under the Offering have a statutory hold period until September 30, 2020. The Company has applied to the Canadian Securities Exchange (the "CSE") for listing approval for the Common Shares underlying the Units and Common Shares to be issued upon exercise of the Warrants.</p> <p align="justify">The Company intends to use proceeds from the Offering for optimization of its Delta, BC facility (including a lights upgrade and outdoor grow), the launch of cannabis ...</p><p><a href=https://www.benzinga.com/pressreleases/20/06/g16185017/rubicon-organics-closes-final-2-0-million-tranche-of-13-5-million-upsized-private-placement alt=Rubicon Organics Closes Final $2.0 Million Tranche of $13.5 Million Upsized Private Placement>Full story available on Benzinga.com</a></p> CSE:ROMJ ROMJF Markets Press Releases Thu, 04 Jun 2020 21:00:10 +0000 Globe Newswire 16185017 at https://www.benzinga.com Report: GM Starting Electric Delivery Van Program https://www.benzinga.com/news/20/06/16184840/report-gm-starting-electric-delivery-van-program <p><strong><a href="https://www.gm.com/">General Motors Co.</a></strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gm#NYSE">GM</a>) is planning an electric delivery van, adding to the list of carmakers and startups planning vehicles for the last-mile delivery segment, according to a <a href="https://www.reuters.com/article/us-autos-electric-vans-exclusive/exclusive-gm-plans-electric-van-for-business-users-in-bid-to-pre-empt-tesla-idUSKBN23B1G1">Reuters report.</a></p> <p>  </p> <p>The GM electric van is code-named BV1, the report stated, and is due to go into production in late 2021 at the automaker&#039;s Detroit-Hamtramck factory.</p> <p>GM spokesman Stuart Fowle said the company is not confirming the news. The automaker has said previously that it will build several other electric vehicles at the plant, which is scheduled to reopen in 2021.</p> <p>"General Motors is committed to an all-electric future and is implementing a multi-segment, scalable EV strategy to get there," Fowle said in an emailed statement to FreightWaves.  "At this time, we do not have any announcements to make ...</p><p><a href=https://www.benzinga.com/news/20/06/16184840/report-gm-starting-electric-delivery-van-program alt=Report: GM Starting Electric Delivery Van Program>Full story available on Benzinga.com</a></p> AMZN electric vehicles F Freight GM News Markets AMZN US0231351067 F US3453708600 GM US37045V1008 News Markets Benzinga Thu, 04 Jun 2020 20:49:34 +0000 FreightWaves 16184840 at https://www.benzinga.com Has Freight Avoided A Great Recession? – Midday Market Update (With Video) https://www.benzinga.com/news/20/06/16184386/has-freight-avoided-a-great-recession-midday-market-update-with-video <p>On today&#039;s Midday Market Update, Michael Vincent and Kevin Hill are talking about the SONAR powered data, issues, and news that moves you. </p> <p>On this episode they&#039;re joined by Jason Miller, Associate Professor of ...</p><p><a href=https://www.benzinga.com/news/20/06/16184386/has-freight-avoided-a-great-recession-midday-market-update-with-video alt=Has Freight Avoided A Great Recession? – Midday Market Update (With Video)>Full story available on Benzinga.com</a></p> Freight News Markets Media News Markets Media Benzinga Thu, 04 Jun 2020 20:25:40 +0000 FreightWaves 16184386 at https://www.benzinga.com What Does Navistar Loss Portend For Other Truck Manufacturers? https://www.benzinga.com/news/earnings/20/06/16184387/what-does-navistar-loss-portend-for-other-truck-manufacturers <p><strong>Navistar International Corp.</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nav#NYSE">NAV</a>) second-quarter fiscal loss from COVID-19-disrupted production in April points to worse numbers for truck manufacturers that will report pandemic-addled results for the April-June quarter.</p> <p>For Navistar, things likely will get worse in its third quarter, which covers May-July. Its second-quarter report on Thursday, June 4, pointed to the difficulties that manufacturers and suppliers will unpack when they report their second-quarter results in July.</p> <p>None of the publicly traded manufacturers, including Navistar, are providing financial guidance because of the uncertainties created by the pandemic. </p> <h2>Orders fall</h2> <p>On a conference call with analysts, Navistar Chairman, CEO and President Troy Clarke shared insight into the early impacts of the health crisis.</p> <p>Class 8 truck orders fell from about 3,000 per week in February to 1,000 a week in April. The drop off was on top of already slowing orders because fleets took so many deliveries of new trucks in 2018 and 2019. Just<a href="https://www.freightwaves.com/news/april-class-8-truck-orders-hit-25-year-low"> 4,100 new Class 8 orders </a>were placed in April across the industry.</p> <p>"As freight demand declined in the quarter, truck utilization dropped and rates fell," Clarke said. "With excess trucking capacity, companies reassessed their needs, especially in the general freight, rental leasing and private fleet segments."</p> <p>About 300 orders, or 2.5% of the company&#039;s backlog, were canceled in April. It has about 25 weeks of Class 6-8 trucks and buses to build based on its ...</p><p><a href=https://www.benzinga.com/news/earnings/20/06/16184387/what-does-navistar-loss-portend-for-other-truck-manufacturers alt=What Does Navistar Loss Portend For Other Truck Manufacturers?>Full story available on Benzinga.com</a></p> Earnings Freight GM NAV News Markets GM US37045V1008 NAV US63934E1082 News Earnings Markets Benzinga Thu, 04 Jun 2020 20:23:28 +0000 FreightWaves 16184387 at https://www.benzinga.com MFDA Hearing Panel accepts settlement agreement with Tanya Castelino https://www.benzinga.com/pressreleases/20/06/n16184498/mfda-hearing-panel-accepts-settlement-agreement-with-tanya-castelino <p xmlns="http://www.w3.org/1999/xhtml"><span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">TORONTO</span>, <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">June 4, 2020</span> /CNW/ - A settlement hearing in the matter of Tanya Francesca Castelino (&#34;Respondent&#34;) was held today in <span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">Toronto, Ontario</span> by electronic hearing before a three-member Hearing Panel of the Central Regional Council of the Mutual Fund Dealers Association of <span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">Canada</span> (&#34;MFDA&#34;).</p> <p xmlns="http://www.w3.org/1999/xhtml">The Hearing Panel accepted the settlement agreement dated <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">May 13, 2020</span> (&#34;Settlement Agreement&#34;) between Staff of the MFDA and the Respondent, as a consequence of which the following sanctions were imposed on the Respondent:</p> <ul xmlns="http://www.w3.org/1999/xhtml" type="disc"> <li xmlns="http://www.w3.org/1999/xhtml">a fine in the amount of <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">$13,500</span>; </li> <li xmlns="http://www.w3.org/1999/xhtml">costs in the amount of <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">$2,500</span>; and </li> <li xmlns="http://www.w3.org/1999/xhtml">shall in the future comply with ...</li></ul><p><a href=https://www.benzinga.com/pressreleases/20/06/n16184498/mfda-hearing-panel-accepts-settlement-agreement-with-tanya-castelino alt=MFDA Hearing Panel accepts settlement agreement with Tanya Castelino>Full story available on Benzinga.com</a></p> Banking/Financial Services Mutual Funds Markets Press Releases Thu, 04 Jun 2020 20:22:00 +0000 PRNewswire 16184498 at https://www.benzinga.com Bitcoin, Ethereum & Litecoin - American Wrap 6/4 https://www.benzinga.com/markets/cryptocurrency/20/06/16184383/bitcoin-ethereum-litecoin-american-wrap-64 <h2 class="fxs_headline_medium"><a href="https://www.fxstreet.com/cryptocurrencies/news/bitcoin-price-analysis-btc-usd-approaching-10-000-again-confluence-detector-202006041759">Bitcoin Price Analysis: BTC/USD approaching $10,000 again - Confluence Detector</a></h2> <p>With Bitcoin getting close to the critical $10,000 resistance level, it&rsquo;s important to look for areas and points of resistance around this level. BTC/USD is trading at $9,800 at the time of writing.</p> <p>The Technical Confluence Indicator is not showing a lot of resistance points towards $10,000. The major resistance area is close at $9,821 where the Pivot Point 1 Week R1 is currently standing.</p> <p><a href="https://editorial.fxstreet.com/miscelaneous/242c595050e6e5e4b5d67ae06ebcca35-637268902938474316-637268962242398578.png"><img alt="" src="https://editorial.fxstreet.com/miscelaneous/242c595050e6e5e4b5d67ae06ebcca35-637268902938474316-637268962242398578.png" style="left:-93.5px; max-width:747px; position:relative" ...</a></p><p><a href=https://www.benzinga.com/markets/cryptocurrency/20/06/16184383/bitcoin-ethereum-litecoin-american-wrap-64 alt=Bitcoin, Ethereum &amp; Litecoin - American Wrap 6/4>Full story available on Benzinga.com</a></p> BTC Cryptocurrency ETH FXStreet LTC News Forex Markets News Cryptocurrency Forex Markets Benzinga Thu, 04 Jun 2020 20:17:16 +0000 FXStreet 16184383 at https://www.benzinga.com AUD/USD Forecast: With A Limited Bearish Scope Despite Some Signs Of Bullish Exhaustion https://www.benzinga.com/news/20/06/16184277/audusd-forecast-with-a-limited-bearish-scope-despite-some-signs-of-bullish-exhaustion <h2 class="fxs_headline_medium">AUD/USD Current Price: 0.6937</h2> <ul> <li><strong>Australian data keeps beating the market&rsquo;s expectations and backing the Aussie.</strong></li> <li><strong>The poor performance of global indexes put a cap to the AUD/USD pair&rsquo;s advance.</strong></li> <li><strong>AUD/USD with a limited bearish scope despite some signs of bullish exhaustion.</strong></li> </ul> <p><a href="https://www.fxstreet.com/rates-charts/chart-interactive?asset=audusd&amp;config=https://editorial.blob.core.windows.net:443/chartconfigs/valeria/audusd4hval.json" target="_blank"><img alt="" src="https://editorial.fxstreet.com/miscelaneous/AUD_USD-637268972511095526.png" style="left:-93.5px; max-width:747px; position:relative" /></a></p> <p>The AUD/USD pair has surpassed its previous monthly high for a couple of pips closing in the green yet spending most of this Thursday within familiar levels. The intraday peak at 0.6987 was achieved within the ECB ...</p><p><a href=https://www.benzinga.com/news/20/06/16184277/audusd-forecast-with-a-limited-bearish-scope-despite-some-signs-of-bullish-exhaustion alt=AUD/USD Forecast: With A Limited Bearish Scope Despite Some Signs Of Bullish Exhaustion>Full story available on Benzinga.com</a></p> AUD/USD FXStreet News Forex Markets News Forex Markets Benzinga Thu, 04 Jun 2020 20:11:48 +0000 Valeria Bednarik - Chief Analyst at FXStreet 16184277 at https://www.benzinga.com EUR/USD Forecast: Bullish Despite Overbought, Profit-Taking Possible Ahead Of The Weekend https://www.benzinga.com/news/20/06/16184235/eurusd-forecast-bullish-despite-overbought-profit-taking-possible-ahead-of-the-weekend <h2 class="fxs_headline_medium">EUR/USD Current Price: 1.1336</h2> <ul> <li><strong>The ECB expanded its coronavirus-related stimulus program by &euro;600 billion.</strong></li> <li><strong>US employment data suggest the Nonfarm Payroll report will post another outrageous month.</strong></li> <li><strong>EUR/USD bullish despite overbought, profit-taking possible ahead of the weekend.</strong></li> </ul> <p><a href="https://www.fxstreet.com/rates-charts/chart-interactive?asset=eurusd&amp;config=https://editorial.blob.core.windows.net:443/chartconfigs/valeria/eurusd4hval.json" target="_blank"><img alt="" src="https://editorial.fxstreet.com/miscelaneous/EUR_USD-637268968715364952.png" style="left:-93.5px; max-width:747px; position:relative" /></a></p> <p>The EUR/USD has extended its latest advance to a fresh multi-week high of 1.1362, ending the day with substantial gains above the 1.1300 threshold. The <a href="https://www.fxstreet.com/macroeconomics/central-banks/ecb">European Central Bank</a> had a monetary policy meeting, living rates unchanged as widely expected, but also expanding its PEPP program by &euro;600 billion and extended its stimulus scheme until June 2021, somehow anticipating that the recovery will take longer. The central bank also downgraded its growth and inflation forecast for this ...</p><p><a href=https://www.benzinga.com/news/20/06/16184235/eurusd-forecast-bullish-despite-overbought-profit-taking-possible-ahead-of-the-weekend alt=EUR/USD Forecast: Bullish Despite Overbought, Profit-Taking Possible Ahead Of The Weekend>Full story available on Benzinga.com</a></p> EUR/USD FXStreet News Eurozone Forex Markets News Eurozone Forex Markets Benzinga Thu, 04 Jun 2020 20:09:32 +0000 Valeria Bednarik - Chief Analyst at FXStreet 16184235 at https://www.benzinga.com Aeterna Zentaris Receives Extension From Nasdaq to Satisfy Continuing Listing Requirements https://www.benzinga.com/pressreleases/20/06/g16184154/aeterna-zentaris-receives-extension-from-nasdaq-to-satisfy-continuing-listing-requirements <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p align="justify">CHARLESTON, S.C., June 04, 2020 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=uKK2kRrGzTs7cCeu5OVYCXVL3zybAW0--qA_0olZHj7cQgmD_rALDaq6fifPetfg4lPYnIsZG_7R5cItROw6EFRjkMgBc9A3ecHDtUhgg5M=" rel="nofollow" target="_blank" rel="nofollow"><u>Aeterna Zentaris Inc.</u></a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEZS#NASDAQ" rel="nofollow">AEZS</a>) (TSX:<a class="ticker" href="https://www.benzinga.com/stock/AEZS#TSX" rel="nofollow">AEZS</a>) ( the "Company"), a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests, today announced that the Company has received a positive decision from the staff of the Listing Qualifications Department of The Nasdaq Stock Market LLC (the "Staff"), granting the Company&#039;s request for an extension through October 5, 2020 to achieve compliance with the minimum $2.5 million stockholders‘ equity requirement for continued listing on The Nasdaq Capital Market. The Staff&#039;s determination followed the Company&#039;s submission of its compliance plan for the Staff&#039;s consideration on May 26, 2020. <br /></p> <p align="justify">The Company is pursuing a number of initiatives to increase stockholders‘ equity, the completion of which are expected to enable it to achieve compliance with the minimum stockholders&#039; equity requirement by no later than October 5, 2020 and to thereafter maintain compliance with the listing requirements.</p> <p align="justify"><strong>About Aeterna Zentaris Inc.</strong></p> <p align="justify">Aeterna Zentaris Inc. is a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests. The Company&#039;s lead product, Macrilen™ (macimorelin), is the first and only U.S. FDA and European Commission approved oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). Macrilen™ is currently marketed in the United States through a license agreement with Novo Nordisk and Aeterna Zentaris receives double-digit royalties on sales. Aeterna Zentaris owns all rights to macimorelin outside of the U.S. and Canada.</p> <p align="justify">Aeterna Zentaris is also leveraging the clinical success and compelling safety profile of macimorelin to develop it for the diagnosis of child-onset growth hormone deficiency (CGHD), an area of significant unmet need. </p> <p align="justify">The Company is actively pursuing business development opportunities for the commercialization ...</p><p><a href=https://www.benzinga.com/pressreleases/20/06/g16184154/aeterna-zentaris-receives-extension-from-nasdaq-to-satisfy-continuing-listing-requirements alt=Aeterna Zentaris Receives Extension From Nasdaq to Satisfy Continuing Listing Requirements>Full story available on Benzinga.com</a></p> AEZS TSX:AEZS Markets Press Releases Thu, 04 Jun 2020 20:05:10 +0000 Globe Newswire 16184154 at https://www.benzinga.com Menlo Therapeutics Announces Proposed Offering of Common Stock https://www.benzinga.com/pressreleases/20/06/g16183983/menlo-therapeutics-announces-proposed-offering-of-common-stock <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p>BRIDGEWATER, N.J., June 04, 2020 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. ("Menlo") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNLO#NASDAQ" rel="nofollow">MNLO</a>), a specialty pharmaceutical company focused on developing and commercializing proprietary therapies to address unmet needs in dermatology, today announced that it intends to offer and sell, subject to market conditions, shares of its common stock in an underwritten public offering. All of the common stock to be sold in the offering will be offered by Menlo. In addition, Menlo expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or the actual size or terms of the offering.<br /></p> <p>Cowen and Piper Sandler &amp; Co. are acting as joint book-runners for the proposed offering. LifeSci Capital LLC is acting as lead manager.</p> <p>A shelf registration statement relating to these securities was previously filed with the Securities and Exchange Commission ("SEC") and declared effective on February 12, 2019. A preliminary prospectus supplement relating to and describing the terms of the offering will be filed with the SEC and will be available on the SEC&#039;s web site at <a href="http://www.sec.gov" title="www.sec.gov" rel="nofollow">www.sec.gov</a>. Copies of the preliminary prospectus supplement and the accompanying prospectus relating to these securities may also be obtained, when available, from Cowen and Company, LLC c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY, 11717, Attention: Prospectus Department, by email at <a href="mailto:PostSaleManualRequests@broadridge.com" rel="nofollow">PostSaleManualRequests@broadridge.com</a> or by telephone at (833) 297-2926; or Piper Sandler &amp; Co., Attention: Prospectus Department, 800 Nicollet Mall, J12S03, Minneapolis, Minnesota 55402, by telephone at (800) 747-3924 or by email at <a ...</p><p><a href=https://www.benzinga.com/pressreleases/20/06/g16183983/menlo-therapeutics-announces-proposed-offering-of-common-stock alt=Menlo Therapeutics Announces Proposed Offering of Common Stock>Full story available on Benzinga.com</a></p> MNLO Markets Press Releases Thu, 04 Jun 2020 20:01:10 +0000 Globe Newswire 16183983 at https://www.benzinga.com